Login / Signup

Lepodisiran, an siRNA targeting lipoprotein(a) for the potential future treatment of cardiovascular disease.

P Mihika S FernandoAmanda J HooperJohn R Burnett
Published in: Expert opinion on investigational drugs (2024)
Keyphrases
  • cardiovascular disease
  • cancer therapy
  • type diabetes
  • current status
  • risk assessment